MOXIVAL CV 625 Tablets – Advanced Strength for Advanced Infection Control.
MOXIVAL CV 625 Tablets – The Dual composition of Amoxycillin & Potassium Clavulanate Tablets IP 625 MG effectively treats infections caused by β-lactamase-producing bacteria and improves clinical outcomes compared to amoxicillin alone.
Amoxicillin is a broad‑spectrum penicillin antibiotic that disrupts bacterial cell wall synthesis by binding to penicillin-binding proteins, ultimately causing bacterial lysis.
Clavulanate irreversibly deactivates β-lactamase, shielding amoxicillin from degradation and restoring its potency against resistant organisms.
Key Benefits of Amoxycillin & Potassium Clavulanate Tablets – MOXIVAL CV 625 Tablets
✅Enhanced Spectrum of Action – The combination of amoxicillin and potassium clavulanate delivers potent activity against both Gram-positive and Gram-negative bacteria, including those producing β-lactamase enzymes.
✅Proven Clinical Outcomes – Demonstrates high cure rates in respiratory tract, urinary tract, skin, and soft tissue infections, supported by decades of global clinical use.
✅Dual-Component Synergy – The synergistic effect of amoxicillin and clavulanate delivers superior efficacy compared to amoxicillin monotherapy, especially in community-acquired infections.
Recommended By Specialists:
👨⚕️General Physicians: This combination is predominantly prescribed by general practitioners for managing upper and lower respiratory tract infections, urinary tract infections, and skin and soft tissue infections.
👨⚕️Pulmonologists (Chest Specialists): It commonly use the amoxicillin–clavulanate duo to treat bronchitis, community‑acquired pneumonia, sinusitis, and other lung infections, especially when caused by β‑lactamase‑producing (resistant) bacteria.
👨⚕️Urologists: It is typically considered a second‑line option following first‑line agents like nitrofurantoin or trimethoprim‑sulfamethoxazole.
INDICATIONS:
✅ Skin and soft tissue infections
✅ Urinary tract infections (UTIs)
✅ Otitis media and sinusitis
✅ Bone and joint infections